Learn more

HANMI FINE CHEMICAL CO LTD

Overview
  • Total Patents
    61
  • GoodIP Patent Rank
    32,354
  • Filing trend
    ⇩ 27.0%
About

HANMI FINE CHEMICAL CO LTD has a total of 61 patent applications. It decreased the IP activity by 27.0%. Its first patent ever was published in 1993. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and macromolecular chemistry and polymers are WUHAN JASON BIOTECH CO LTD, FIRM CHEM FAB AUF ACTIEN and GILBERT THOMAS MORGAN.

Patent filings per year

Chart showing HANMI FINE CHEMICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cho Young Bum 21
#2 Lee Jae Heon 20
#3 Chang Young Kil 19
#4 Park Eun Rang 17
#5 Lee Jae Koo 15
#6 Chu Jun Ho 14
#7 Kwon Bo Sung 12
#8 Chang Young-Kil 10
#9 Choi Won Kyoung 10
#10 Kim Yu Rim 8

Latest patents

Publication Filing date Title
WO2020167010A1 Novel intermediate used for biologically active polypeptide and method for preparing same
WO2020017919A1 Novel intermediate used for physiologically active polypeptide and method for preparing same
CN111372911A Polyethylene glycol derivative and preparation method thereof
KR20180124400A Sacubitril conjugate, preparation method thereof, and pharmaceutical composition comprising the same
KR20180124428A Crystalline form of sacubitril hemisodium salt, preparation method thereof, and pharmaceutical composition comprising the same
KR20180013563A Improved method for preparing high purity crystalline febuxostate
KR20170100842A Method for preparing polyethylene glycol dialdehyde derivatives
CN106687467A Method for preparing high-purity (r)-9-[2-(phosphonomethoxy)propyl]adenine
KR20170033684A Crystalline form of linagliptin and preparation method thereof
KR20160146428A Stable amorphous solifenacin pharmaceutical composition containing solifenacin or its pharmaceutically acceptable salt and lactose, and method of preparation thereof
KR20160143407A Novel varenicline mucate, crystalline form thereof, and method of preparation thereof
KR20150135110A PHARMACEUTICAL COMPOSITION COMPRISING p-GLYCOPROTEIN INHIBITOR AND p-GLYCOPROTEIN SUBSTRATE DRUG
KR20160126697A Novel crystalline varenicline oxalate hydrate, preparation method thereof, and pharmaceutical composition comprising same
KR20150098565A Novel intermediate used for the preparation of silodosin, method for preparing same, and method for preparing silodosin using same
KR20160081089A Preparation method for (r)-9-[2-(phosphonomethoxy)propyl]adenine with high purity
KR20160038627A Preparation method for (r)-9-[2-(phosphonomethoxy)propyl]adenine with high purity
KR20160031335A Novel complex of dapagliflozin and piperazine and method for preparing same
KR20160026468A Novel Dabigatran Etexilate Hemisuccinate and Method for Preparing Same
KR20160016025A Novel hydrate complex of dapagliflozin and method for preparing same
KR20160013770A Novel crystalline complex of dapagliflozin and method for preparing same